Evidence map›Paper›PMID 30231595›Full record

ArticleNutrients2018

Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol.

Janin Henkel, Eugenia Alfine, Juliana Saín, Korinna Jöhrens, Daniela Weber, José P Castro, Jeannette König, Christin Stuhlmann, Madita Vahrenbrink, Wenke Jonas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic potential of fish collagen hydrolysates in osteoporosis prevention: a narrative review based on cellular, molecular, and clinical evidence.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Attenuating effect ofFrontiers in pharmacology · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Janin HenkelDepartment of Nutritional Biochemistry, Institute of Nutritional Science, University of Potsdam, D-14558 Nuthetal, Germany. jhenkel@uni-potsdam.de.ORCID 0000-0003-1450-5838
Eugenia AlfineGerman Institute of Human Nutrition, Junior Research Group Central Regulation of Metabolism; D-14558 Nuthetal, Germany. Eugenia.Alfine@dife.de.
Juliana SaínDepartment of Nutritional Biochemistry, Institute of Nutritional Science, University of Potsdam, D-14558 Nuthetal, Germany. jsain@fbcb.unl.edu.ar.ORCID 0000-0002-4026-5367
Korinna JöhrensInstitute of Pathology, Carl Gustav Carus University Hospital Dresden; D-01307 Dresden, Germany. korinna.joehrens@uniklinikum-dresden.de.
Daniela WeberDepartment of Molecular Toxicology, German Institute of Human Nutrition; D-14558 Nuthetal, Germany. Daniela.Weber@dife.de.
José P CastroDepartment of Molecular Toxicology, German Institute of Human Nutrition; D-14558 Nuthetal, Germany. Jose.Castro@dife.de.
Jeannette KönigDepartment of Molecular Toxicology, German Institute of Human Nutrition; D-14558 Nuthetal, Germany. Jeannette.Koenig@dife.de.
Christin StuhlmannDepartment of Nutritional Biochemistry, Institute of Nutritional Science, University of Potsdam, D-14558 Nuthetal, Germany. stuhlman@uni-potsdam.de.
Madita VahrenbrinkDepartment of Nutritional Biochemistry, Institute of Nutritional Science, University of Potsdam, D-14558 Nuthetal, Germany. vahrenbrink@uni-potsdam.de.
Wenke JonasGerman Center for Diabetes Research (DZD), D-85764 München-Neuherberg, Germany. Wenke.Jonas@dife.de.
André KleinriddersGerman Institute of Human Nutrition, Junior Research Group Central Regulation of Metabolism; D-14558 Nuthetal, Germany. Andre.Kleinridders@dife.de.
Gerhard P PüschelDepartment of Nutritional Biochemistry, Institute of Nutritional Science, University of Potsdam, D-14558 Nuthetal, Germany. gpuesche@uni-potsdam.de.
University of Potsdam · DEDeutsches Diabetes-Zentrum e.V. · DEGerman Institute of Human Nutrition · DEBrigham and Women's Hospital · USUniversity Hospital Carl Gustav Carus · DE

Funding

Deutsche Forschungsgemeinschaft HE-7032/1-1
6 · The paper itself

Abstract

While the impact of dietary cholesterol on the progression of atherosclerosis has probably been overestimated, increasing evidence suggests that dietary cholesterol might favor the transition from blunt steatosis to non-alcoholic steatohepatitis (NASH), especially in combination with high fat diets. It is poorly understood how cholesterol alone or in combination with other dietary lipid components contributes to the development of lipotoxicity. The current study demonstrated that liver damage caused by dietary cholesterol in mice was strongly enhanced by a high fat diet containing soybean oil-derived ω6-poly-unsaturated fatty acids (ω6-PUFA), but not by a lard-based high fat diet containing mainly saturated fatty acids. In contrast to the lard-based diet the soybean oil-based diet augmented cholesterol accumulation in hepatocytes, presumably by impairing cholesterol-eliminating pathways. The soybean oil-based diet enhanced cholesterol-induced mitochondrial damage and amplified the ensuing oxidative stress, probably by peroxidation of poly-unsaturated fatty acids. This resulted in hepatocyte death, recruitment of inflammatory cells, and fibrosis, and caused a transition from steatosis to NASH, doubling the NASH activity score. Thus, the recommendation to reduce cholesterol intake, in particular in diets rich in ω6-PUFA, although not necessary to reduce the risk of atherosclerosis, might be sensible for patients suffering from non-alcoholic fatty liver disease.

Indexed as

Cholesterol, DietaryAnimalsCell DeathDisease Models, AnimalFatty Acids, Omega-6Lipid PeroxidationLiverMaleMice, Inbred C57BLMitochondria, LiverNon-alcoholic Fatty Liver DiseaseOxidative StressSoybean OilCholesterol, DietaryFatty Acids, Omega-6Soybean OilcholesterolinflammationNASHnon-alcoholic fatty liver disease (NAFLD)oxidative stressPUFA

Identifiers

PMID30231595
PMCPMC6164134
OpenAlexW2890749350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.